Screening, Treatment, and Eradication of Hep C

Launched by LIVER INSTITUTE PLLC · Sep 27, 2021

Keywords

ClinConnect Summary

This clinical trial, titled "Screening, Treatment, and Eradication of Hep C," aims to find out how well different ways of communication—like text messages, emails, social media, radio ads, newspapers, and flyers—can help identify people in Arizona who might have Hepatitis C (HCV). Hepatitis C is a virus that affects the liver and can lead to serious health problems if not treated. The study is looking for participants who are at least 15 years old and willing to sign a consent form to take part in the screening process.

If you or someone you know is interested in the study, it’s important to know that participants must not already have a diagnosis of Hepatitis C or have had a liver transplant. The trial is currently not recruiting, which means it’s not yet looking for participants, but it will be soon. Those who join can expect to be part of an effort to improve HCV screening in the community, which could help many people get the care they need.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects must sign the consent to screen and take part in the study.
• • Subjects must be at least 15 years of age
• Exclusion Criteria:
• • Patients will only be enrolled once
• • Patients who do not meet the inclusion criteria
• • Patients with a current HCV diagnosis
• • Patients who underwent a liver transplant